Silence Therapeutics Plc (SLN.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 517 | 490 | 407 | N/A | N/A |
| Income taxes - deferred | 1,388 | N/A | N/A | N/A | N/A |
| Accounts receivable | -23 | -350 | 27 | 1,034 | -66 |
| Other Working Capital | 81 | 206 | 19 | 407 | -4,459 |
| Other Operating Activity | -16,681 | -11,487 | -8,334 | -9,376 | -11,758 |
| Operating Cash Flow | $-14,718 | $-11,141 | $-7,880 | $-7,935 | $-16,283 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -525 | -198 | 19 | -410 | -350 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,151 |
| Purchase Of Investment | 0 | -8,245 | N/A | -9 | N/A |
| Sale Of Investment | N/A | 0 | 63 | N/A | N/A |
| Purchase Sale Intangibles | -2 | -30 | -322 | N/A | N/A |
| Other Investing Activity | 213 | 66 | 24 | 42 | 59 |
| Investing Cash Flow | $-313 | $-8,407 | $-215 | $-377 | $860 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -2,994 |
| Common Stock Issued | 16,878 | 30,975 | 16,561 | 8,569 | 22,160 |
| Financing Cash Flow | $16,878 | $30,975 | $16,561 | $8,569 | $19,166 |
| Exchange Rate Effect | -342 | 84 | -31 | -68 | 17 |
| Beginning Cash Position | 24,732 | 14,691 | 5,960 | 5,538 | 1,746 |
| End Cash Position | 26,237 | 26,203 | 14,397 | 5,726 | 5,505 |
| Net Cash Flow | $1,848 | $11,428 | $8,468 | $256 | $3,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,718 | -11,141 | -7,880 | -7,935 | -16,283 |
| Capital Expenditure | -526 | -228 | -326 | -425 | -452 |
| Free Cash Flow | -15,244 | -11,368 | -8,206 | -8,361 | -16,735 |